The recently appointed Chief Pharmaceutical Officer (CPhO) for England, David Webb, delivered a keynote speech in person at the National Meeting of LPCs and PSNC on Thursday 17th May 2022. As the new head of the pharmacy professions, he set out his personal priorities for the next few years. At the start of his speech,
Read more
PSNC Chief Executive Janet Morrison has recorded a video message for community pharmacy contractors about her personal reflections on the proposals for the future of PSNC and LPCs made by the Pharmacy Representation Review Steering Group (RSG). In the video, Janet recognises the proposals as sensible and practical steps that any modern and forward-thinking sector
Read more
Following our previous announcement that the NHS prescription charge would not be uplifted on 1st April 2022, the Department of Health and Social Care has now announced that NHS prescription charges in England will remain frozen for the rest of 2022/23. This is the first time in 12 years that the charge has not increased.
Read more
PSNC is seeking to recruit a Regulations Officer to support its legislative and regulatory affairs work. The appointee – Regulations Officer – will be responsible for providing guidance and support to pharmacy contractors, Local Pharmaceutical Committees and others on NHS related legislative and regulatory matters. The postholder will have the opportunity to manage their own projects
Read more
Update 13/05/2022 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Fluoxetine 10mg tablets (SSP005). SSP005 for Fluoxetine 10mg tablets was previously expected to expire on 13 May 2022 but the end date has been further extended to Friday 12 August 2022. Update 10/02/2022
Read more
10,797 pharmacy contractors who declared their April 2022 FP34C submission figures through the Manage Your Service (MYS) portal by 6 May 2022 received their earlier advance payments on Thursday 12 May 2022 (circa 20 days earlier than the normal advance payment timetable). This leaves c.400 contractors who did not receive any earlier advance payments in
Read more
The NHS Business Services Authority (NHSBSA) report seeing a rise in items that are being referred back (RB) to contractors for the reason code RB2B: ‘The order/endorsement is incomplete. The presentation must be present.’ The NHSBSA note that this issue is most commonly seen with handwritten prescriptions. Where prescription does not specify the presentation of a drug
Read more
NHS Prescription Services produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 47) contains some useful information and advice on: The new NHS Profile ManagerRequest for feedback on the Drug TariffMYS system downtimeHow to avoid refer backsA reminder to submit FP34C claims on time To view current and previous
Read more
Community pharmacy representatives have today attended a Government meeting about disruptions to the supply of Hormone Replacement Therapy (HRT) medicines. Following growing public concern about obtaining HRT drugs, Health and Social Care Secretary Sajid Javid convened a round table discussion with key stakeholders across the supply chain, including community pharmacy. Manufacturers and suppliers of a
Read more
Following the Department of Health and Social Care’s (DHSC) announcement of three new Serious Shortage Protocols (SSPs) for Hormone Replacement Therapy (HRT) medicines, PSNC has created a briefing titled ‘HRT Serious Shortage Protocols (SSPs) FAQs‘ to help pharmacists understand the requirements of these SSPs. In addition, to support pharmacy teams, PSNC has also put together some helpful
Read more
